Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Merck describes preparation and use of new anticoagulants

April 5, 2000

Novel anticoagulant presented by Ajinomoto at Japanese Pharmacological Society meeting

April 3, 2000

Novel antiplatelet agents in the Searle pipeline

April 3, 2000

Highly potent and orally bioavailable nonbenzamidine factor Xa inhibitors presented to ACS

March 29, 2000

3-Dimensional Pharmaceuticals begins clinical testing of oral thrombin inhibitor

March 29, 2000

Nonpeptide protease inhibitors designed and evaluated at 3-D

March 28, 2000

CPMP recommends approval of Kogenate Bayer as hemophilia A treatment

March 27, 2000

Orally bioavailable gpIIb/IIIa receptor antagonist ME-3230 profiled at Japanese meeting

March 27, 2000

Na/Ca2+ exchange inhibitor KB-R7943 evaluated for effects on platelet aggregation

March 24, 2000

Functional studies confirm potent 5-HT2A-antagonist activity of AT-1015

March 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...